Clene Inc. buy krebskrebs
Start price
19.04.22
/
50%
€2.74
Target price
19.04.23
€5.00
Performance (%)
-67.34%
End price
20.04.23
€0.90
Summary
This prediction ended on 20.04.23 with a price of €0.90. The BUY prediction by krebskrebs for Clene Inc. performed very badly with a performance of -67.34%. krebskrebs has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Clene Inc. | - | - | - |
iShares Core DAX® | 0.238% | -2.265% | 13.679% |
iShares Nasdaq 100 | -0.304% | 5.808% | 34.538% |
iShares Nikkei 225® | 2.271% | 1.577% | 9.436% |
iShares S&P 500 | -0.296% | 4.447% | 28.577% |
Comments by krebskrebs for this prediction
In the thread Clene Inc. diskutieren
Buy mit Kursziel 5,0
In the thread Trading Clene Inc.
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten